Hyster-Yale Director Receives 963 Class A Shares, Holdings 18,683 (Form 4)
Rhea-AI Filing Summary
James Bemowski, a director of HYSTER-YALE, INC. (HY), was awarded 963 shares of Class A Common Stock on 10/01/2025 as required equity compensation for non-employee directors. Following this award, Bemowski beneficially owns 18,683 shares of Class A Common Stock. The transaction is reported as an acquisition at a $0 price because these were award shares issued under the company Non-Employee Directors' Equity Compensation Plan.
The Form 4 filing was executed on 10/02/2025 by Suzanne S. Taylor as attorney-in-fact. The report is a single-person filing and identifies Bemowski as a director. No derivative transactions, cash payments, or changes to previously reported holdings are disclosed in this form.
Positive
- Director alignment via issuance of 963 "Required Shares" supports alignment of the director's interests with shareholders
- Clear disclosure of acquisition date (10/01/2025), share count (963), and post-transaction beneficial ownership (18,683)
Negative
- None.
Insights
TL;DR: Director received required equity award of 963 shares, increasing his holdings to 18,683 shares; routine governance disclosure.
The transaction is a standard grant of "Required Shares" under the non-employee director equity plan, reported as an acquisition with no cash consideration. Such awards are common to align director interests with shareholders and are typically non-material individually unless the director already holds a substantial stake. The filing shows no sales, option exercises, or other compensatory changes beyond the share award, and it was timely executed by an attorney-in-fact.
TL;DR: Form 4 accurately reports a routine director equity award; disclosure appears complete for the described transaction.
The form documents the acquisition date (10/01/2025), the award quantity (963 Class A shares), and post-transaction beneficial ownership (18,683 shares). The use of transaction code A(1) and a $0 price is consistent with shares issued as compensation. No derivative positions or additional relationships are indicated beyond director status. Signature by attorney-in-fact on 10/02/2025 satisfies the reporting signature requirement noted on the form.